These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28010007)

  • 1. VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3.
    Crowther M; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1026-1027. PubMed ID: 28010007
    [No Abstract]   [Full Text] [Related]  

  • 2. Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2.
    Crowther M; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1025. PubMed ID: 28010006
    [No Abstract]   [Full Text] [Related]  

  • 3. 2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1.
    Crowther M; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1024. PubMed ID: 28010005
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and treatment of venous thromboembolism during pregnancy.
    Weitz JI
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S22-6. PubMed ID: 19213066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended therapy for primary and secondary prevention of venous thromboembolism.
    Conway SE; Marcy TR
    J Pharm Pract; 2010 Aug; 23(4):313-23. PubMed ID: 21507831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.
    Burnett AE; Mahan CE; Vazquez SR; Oertel LB; Garcia DA; Ansell J
    J Thromb Thrombolysis; 2016 Jan; 41(1):206-32. PubMed ID: 26780747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into treatment of venous thromboembolism.
    Moll S
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):297-305. PubMed ID: 25696869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients.
    Amin A; Jing Y; Trocio J; Lin J; Lingohr-Smith M; Graham J
    J Med Econ; 2014 Nov; 17(11):763-70. PubMed ID: 25078794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and clots: all cases of venous thromboembolism are not treated the same.
    Babu B; Carman TL
    Cleve Clin J Med; 2009 Feb; 76(2):129-35. PubMed ID: 19188478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.
    Preblick R; Kwong WJ; White RH; Goldhaber SZ
    Hosp Pract (1995); 2015; 43(5):249-57. PubMed ID: 26549305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline update. VTE disease: which agents, and when.
    Holten KB; Merok J
    J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S; Bond S
    Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anticoagulants in the treatment of VTE.
    Le Gal G; Mottier D
    Semin Respir Crit Care Med; 2012 Apr; 33(2):191-8. PubMed ID: 22648492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of anticoagulants used in the treatment of venous thromboembolism.
    Nutescu EA; Burnett A; Fanikos J; Spinler S; Wittkowsky A
    J Thromb Thrombolysis; 2016 Jan; 41(1):15-31. PubMed ID: 26780737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What NPs need to know about anticoagulation therapy.
    Gay SE; Munaco S
    Nurse Pract; 2012 Oct; 37(10):28-34. PubMed ID: 23014177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing challenging patients with venous thromboembolism: a practical, case-based approach.
    Douketis J; Ageno W; Carrier M; Kearon C
    Pol Arch Intern Med; 2017 Jan; 127(1):41-46. PubMed ID: 28075424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of venous thromboembolism.
    Wells PS; Forgie MA; Rodger MA
    JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic implications of inadequate treatment of venous thromboembolism and potential solutions.
    Dobesh PP
    J Pharm Pract; 2014 Apr; 27(2):178-86. PubMed ID: 24366976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.